ISATHAL EYE GEL DIN 02427869
Health Canada record
| Active ingredient(s) | FUSIDIC ACID 10 MG |
|---|---|
| Dosage form | Gel |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 26-Feb-2015 |
| Current status date | 26-Feb-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Dechra Veterinary Products Inc. — licence 102149, currently licensed, last inspection rating C (2025-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FUSIDIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02474883 | FUCIBET | LEO PHARMA INC | Cream | FUSIDIC ACID 2 %; BETAMETHASONE (BETAMETHASONE VALERATE) 0.1 % | Marketed |
| 00586668 | FUCIDIN CREAM 2% | LEO PHARMA INC | Cream | FUSIDIC ACID 2 % | Marketed |
| 02238578 | FUCIDIN H | LEO PHARMA INC | Cream | FUSIDIC ACID 2 %; HYDROCORTISONE ACETATE 1 % | Marketed |
| 02243862 | FUCITHALMIC | AMDIPHARM LIMITED | Drops | FUSIDIC ACID 1 % | Marketed |
| 02427850 | ISADERM GEL | DECHRA VETERINARY PRODUCTS A/S | Gel | FUSIDIC ACID 5 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 1 MG | Marketed |
| 02244695 | FUCIDERM GEL | LEO PHARMA INC | Gel | FUSIDIC ACID 5 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 1 MG | Cancelled Post Market |
| 02274884 | FUCIDERM GEL | AVENTIX ANIMAL HEALTH CORP | Gel | FUSIDIC ACID 5 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 1 MG | Cancelled Post Market |
| 00506036 | FUCIDIN LEO SUS 246MG/5ML | LEO PHARMA INC | Suspension | FUSIDIC ACID 246 MG | Cancelled Post Market |
| 02243861 | FUCITHALMIC | AMDIPHARM LIMITED | Drops | FUSIDIC ACID 1 % | Cancelled Post Market |
| 02231118 | FUCITHALMIC VET (VISCOUS EYE DROPS) | LEO PHARMA INC | Solution | FUSIDIC ACID 10 MG | Cancelled Post Market |
| 02279797 | FUCITHALMIC VET EYE GEL | AVENTIX ANIMAL HEALTH CORP | Gel | FUSIDIC ACID 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15814 | 2014-07-15 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for FUSIDIC ACID
1 valid EDQM Certificates of Suitability from 1 holders. 5 active FDA Drug Master Files.
Request a quote for ISATHAL EYE GEL